MTHFR and PMDD

  • Jessica Lloyd Lead Naturopath and founder of My Vagina clinic
    Author: Jessica Lloyd
    Senior Vulvovaginal Specialist Naturopath | BHSc(N) | ISSVD, ISSWSH, BSSM, ATMS

Premenstrual dysphoric disorder (PMDD) may be shaped in part by a genetic predisposition, the MTHFR gene variances, with impaired methylation.

In PMDD, neurotransmitters such as serotonin and dopamine are influenced by oestrogen and progesterone fluctuations in the luteal phase of the menstrual cycle1. That is, from ovulation to the first day of menstrual bleeding.

The symptoms of PMDD include debilitating depression, anxiety, mental impairment and fatigue, amongst others. The nervous system and neurotransmitters are misaligned, though the nature of this is unknown2.

During the methylation cycle, SAMe is produced, resulting in the synthesis and balancing of neurotransmitters.

People with MTHFR gene mutations may not produce sufficient SAMe to ensure proper neurotransmitter production and management. In one study, the MTHFR C677T variant was linked to more premenstrual depression, though mainly in women with low folate intake3. SAMe supplementation has good evidence in depression4, and in our clinical experience it can ease PMDD symptoms for some people in a relatively short space of time.

Why is SAMe so effective in this situation?

Unclear, but a theory is that if you have MTHFR genetic mutation issues and methylation problems, thus not producing sufficient SAMe, the brain likely already has low serotonin levels. In the luteal phase as oestrogen drops, serotonin levels are very low. We need serotonin to stay feeling happy and well.

MTHFR gene variations and methylation issues may not exist independently, with low zinc, B6 and iron all important for neurotransmitter production. Inflammation causes a reduction in neurotransmitters, and research links higher inflammatory markers, such as CRP, with more premenstrual symptoms5.

Getting tested for MTHFR variants will help you move forward in getting the right treatment, and if you need more support, book in with an experienced practitioner.

This article is general information and not a substitute for personalised medical advice. If you are struggling with PMDD symptoms, please see an experienced practitioner.

  1. Tiranini L, Nappi RE. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Faculty Reviews. 2022;11:11.
  2. Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of Stress. 2020;12:100213.
  3. Zeitoun T, El-Sohemy A. Folate intake, MTHFR genotype and premenstrual symptoms. British Journal of Nutrition. 2025;135(6):632-642.
  4. Peng T, Cheng H, Wu T. S-adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: an updated systematic review and meta-analysis. General Hospital Psychiatry. 2024;86:118-126.
  5. Gold EB, Wells C, O’Neill Rasor M. The association of inflammation with premenstrual symptoms. Journal of Women’s Health. 2016;25(9):865-874.


Price range: USD $130.00 through USD $275.00
This product has multiple variants. The options may be chosen on the product page
(9) USD $0.00
(29) USD $0.00
SHARE YOUR CART
0